What this means for you right now: BPC-157 and TB-500 are currently available through licensed compounding pharmacies under clinician supervision Thymosin Alpha-1 has a longer regulatory history and a more established compounding track record Sourcing from unregulated vendors carries real safety risks contamination, misdosing, and no quality control We've covered the full regulatory picture in detail here: PCAC Peptide Review 2026: What the July Advisory Panel Decision Means for BPC-157, TB-500, and Thymosin Alpha-1 What a Clinician-Supervised Long COVID Peptide Protocol Looks Like A responsible protocol starts with assessment not assumption
Ultimately, the oxidizing agent in this reaction is \(NAD^+\), but the reduction of \(NAD^+\) is linked to the oxidative decarboxylation of pyruvate by \(FAD\) and a disulfide-containing coenzyme called lipoamide, which is lipoic acid attached by an amide linkage to a lysine residue on the enzyme
Like, it's and it's crazy because, like, you think about it, it's like we're not far off
What If My Refrigerated 5-Amino-1MQ Was Left Out Overnight
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy
Without robust data, it is hard to distinguish hope from hype
